- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 03.07. | Trial of Bundibugyo Ebola drugs starts in DRC | ||
| 03.07. | Respiratory biotech Celea raises $180m, and other financings | ||
| 03.07. | Newron charts course forward for stalled schizophrenia drug | ||
| 02.07. | Novartis' new SMA gene therapy cleared in EU | ||
| 02.07. | AZ forges ever-closer ties with China's CSPC Pharma | ||
| 02.07. | Almost half of dementia cases could be prevented, says study | ||
| 02.07. | Roche's KRAS drug tops its rivals in lung cancer trial | ||
| 02.07. | Vertex gets paediatric FDA okay for Casgevy gene therapy | ||
| 02.07. | Colorado's pathfinder medicine price-cap move stalls | ||
| 01.07. | NICE guidance calls for quicker diagnosis of PMOS | ||
| 01.07. | Ipsen's M&A team strikes again, adding Memo in $700m deal | ||
| 01.07. | FDA clears Orca's cell therapy Tregzi for GvHD | ||
| 01.07. | Anthropic launches Claude Science for pharma researchers | ||
| 30.06. | Despite study bust, Vistagen still hopes to file anxiety drug | ||
| 30.06. | Brukinsa data raises chemo-free hope for mantle cell lymphoma | ||
| 30.06. | Drugmakers asked to defend Chinese trials; reports | ||
| 30.06. | Unicycive hits another hurdle with hyperphosphataemia drug | ||
| 30.06. | Brukinsa data raise chemo-free hope for mantle cell lymphoma | ||
| 30.06. | Sanofi eyes extending Nexviazyme into infantile Pompe | ||
| 30.06. | Lilly, Regeneron among firms chosen for FDA fast plant pilot | ||
| 29.06. | UK partners with Eli Lilly on obesity plan | ||
| 29.06. | Zymeworks cuts deal to buy Theravance for $929m in cash | ||
| 29.06. | FDA clears Viridian's Tepezza rival for thyroid eye disease | ||
| 29.06. | Ipsen charts $1.75bn course for Kartos acquisition | ||
| 29.06. | EMA advisors say CSL's Tavneos should be pulled from sale |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.